173 related articles for article (PubMed ID: 18712898)
21. A 2'-methyl or 2'-methylene group at G+1 in precursor tRNA interferes with Mg2+ binding at the enzyme-substrate interface in E-S complexes of E. coli RNase P.
Cuzic S; Hartmann RK
Biol Chem; 2007 Jul; 388(7):717-26. PubMed ID: 17570824
[TBL] [Abstract][Full Text] [Related]
22. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
Cho J; Rando RR
Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
[TBL] [Abstract][Full Text] [Related]
23. RNase P RNA mediated cleavage: substrate recognition and catalysis.
Kirsebom LA
Biochimie; 2007 Oct; 89(10):1183-94. PubMed ID: 17624654
[TBL] [Abstract][Full Text] [Related]
24. Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure.
Berchanski A; Lapidot A
Biochim Biophys Acta; 2007 Sep; 1768(9):2107-19. PubMed ID: 17560540
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.
Borovinskaya MA; Pai RD; Zhang W; Schuwirth BS; Holton JM; Hirokawa G; Kaji H; Kaji A; Cate JH
Nat Struct Mol Biol; 2007 Aug; 14(8):727-32. PubMed ID: 17660832
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of eukaryotic ribonuclease P activity by aminoglycosides: kinetic studies.
Tekos A; Tsagla A; Stathopoulos C; Drainas D
FEBS Lett; 2000 Nov; 485(1):71-5. PubMed ID: 11086168
[TBL] [Abstract][Full Text] [Related]
27. Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate.
Borkow G; Lara HH; Lapidot A
Biochem Biophys Res Commun; 2003 Dec; 312(4):1047-52. PubMed ID: 14651977
[TBL] [Abstract][Full Text] [Related]
28. Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites.
Berchanski A; Lapidot A
J Mol Model; 2009 Mar; 15(3):281-94. PubMed ID: 19057930
[TBL] [Abstract][Full Text] [Related]
29. A new class of branched aminoglycosides: pseudo-pentasaccharide derivatives of neomycin B.
Fridman M; Belakhov V; Yaron S; Baasov T
Org Lett; 2003 Oct; 5(20):3575-8. PubMed ID: 14507176
[TBL] [Abstract][Full Text] [Related]
30. Modifications of aminoglycoside antibiotics targeting RNA.
Zhou J; Wang G; Zhang LH; Ye XS
Med Res Rev; 2007 May; 27(3):279-316. PubMed ID: 16892199
[TBL] [Abstract][Full Text] [Related]
31. A simple structural-based approach to prevent aminoglycoside inactivation by bacterial defense proteins. Conformational restriction provides effective protection against neomycin-B nucleotidylation by ANT4.
Asensio JL; Hidalgo A; Bastida A; Torrado M; Corzana F; Chiara JL; García-Junceda E; Cañada J; Jiménez-Barbero J
J Am Chem Soc; 2005 Jun; 127(23):8278-9. PubMed ID: 15941249
[TBL] [Abstract][Full Text] [Related]
32. NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
Lapidot A; Peled A; Berchanski A; Pal B; Kollet O; Lapidot T; Borkow G
Biochim Biophys Acta; 2008 Jun; 1780(6):914-20. PubMed ID: 18410746
[TBL] [Abstract][Full Text] [Related]
33. A 40.7 kDa Rpp30/Rpp1 homologue is a protein subunit of Dictyostelium discoideum RNase P holoenzyme.
Vourekas A; Kalavrizioti D; Zarkadis IK; Spyroulias GA; Stathopoulos C; Drainas D
Biochimie; 2007 Mar; 89(3):301-10. PubMed ID: 17207566
[TBL] [Abstract][Full Text] [Related]
34. Ionic interactions between PRNA and P protein in Bacillus subtilis RNase P characterized using a magnetocapture-based assay.
Day-Storms JJ; Niranjanakumari S; Fierke CA
RNA; 2004 Oct; 10(10):1595-608. PubMed ID: 15337847
[TBL] [Abstract][Full Text] [Related]
35. Binding thermodynamics of paromomycin, neomycin, neomycin-dinucleotide and -diPNA conjugates to bacterial and human rRNA.
Alguacil J; Robles J; Ràfols C; Bosch E
J Mol Recognit; 2016 Apr; 29(4):142-50. PubMed ID: 26530431
[TBL] [Abstract][Full Text] [Related]
36. A real-time fluorescence polarization activity assay to screen for inhibitors of bacterial ribonuclease P.
Liu X; Chen Y; Fierke CA
Nucleic Acids Res; 2014 Nov; 42(20):e159. PubMed ID: 25249623
[TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro investigation of bacterial type B RNase P interaction with tRNA 3'-CCA.
Wegscheid B; Hartmann RK
Nucleic Acids Res; 2007; 35(6):2060-73. PubMed ID: 17355991
[TBL] [Abstract][Full Text] [Related]
38. Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives.
Hainrichson M; Pokrovskaya V; Shallom-Shezifi D; Fridman M; Belakhov V; Shachar D; Yaron S; Baasov T
Bioorg Med Chem; 2005 Oct; 13(20):5797-807. PubMed ID: 15993084
[TBL] [Abstract][Full Text] [Related]
39. Activation of bacterial ribonuclease P by macrolides.
Toumpeki C; Vourekas A; Kalavrizioti D; Stamatopoulou V; Drainas D
Biochemistry; 2008 Apr; 47(13):4112-8. PubMed ID: 18330998
[TBL] [Abstract][Full Text] [Related]
40. Function of heterologous and truncated RNase P proteins in Bacillus subtilis.
Gösringer M; Hartmann RK
Mol Microbiol; 2007 Nov; 66(3):801-13. PubMed ID: 17919279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
